Abel Hall, LLC Astrazeneca PLC Transaction History
Abel Hall, LLC
- $166 Billion
- Q1 2025
A detailed history of Abel Hall, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Abel Hall, LLC holds 6,251 shares of AZN stock, worth $439,945. This represents 0.28% of its overall portfolio holdings.
Number of Shares
6,251
Previous 4,451
40.44%
Holding current value
$439,945
Previous $292 Million
57.54%
% of portfolio
0.28%
Previous 0.19%
Shares
6 transactions
Others Institutions Holding AZN
# of Institutions
1,428Shares Held
504MCall Options Held
10MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.02 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.86 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.51 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.24 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.2 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $218B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...